Quercetin targets VCAM1 to prevent diabetic cerebrovascular endothelial cell injury
Jiebin Huang1, Weiwei Lin2, Yuxing Sun3
1Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Introduction:
Endothelial cells play important roles in neurodegenerative diseases caused by diabetes, therefore, we aimed at investigating the mechanisms through which endothelial cells are involved in diabetes development.
Methods:
Single cell analysis was performed to identify the major endothelial cell subtypes in cardiovascular tissues that are involved in diabetes development. A cell-cell communication approach was then used to identify ligand-receptor interaction pairs between these cell types. Differential expression analysis between the two experimental groups [standard chow diet group and diabetogenic diet with cholesterol (DDC) group] was used to identify diabetes-related differentially expressed genes (DEGs). The upregulated genes were used to identify candidate ligands or receptors, as well as the corresponding cell types. Cell trajectory inference was performed to identify the stage of cell development and changes in expression of candidate ligands or receptors during cell development. Gene set enrichment analysis (GSEA) was conducted to investigate the biological functions of genes of purpose. Finally, molecular dynamics simulations (MDSs) were used to predict potential drugs with the ability to target the proteins of purpose.
Results:
Seven cell types, including five endothelial cell subtypes (EC_1, EC_2, EC_3, EC_4, and EC_EndMT), were identified from endothelial cell-enriched single cell samples from the heart and aorta of mice. Cell-cell communication analysis revealed the potential ligand-receptor interactions between these cell types while five important ligand-receptor-associated genes, including Fn1, Vcam1, Fbn1, Col4a1, and Col4a2, were established by differential expression analysis. Among them, Vcam1 is mainly expressed in EC_EndMT and is involved in interactions between EC_EndMT and other cells. Cell trajectory extrapolation analysis revealed a shift from EC_2/EC_4 to EC_EndMT and a shift from EC_EndMT to EC_3/EC_1 during the progression of diabetes. GSEA analysis revealed that upregulation of VCAM1 may have inhibitory effects on cell growth and energy metabolism.
Conclusion:
EC_EndMT subtypes have a complex role in neurodegenerative diseases caused by diabetes. Through mechanisms involved in cell-cell communication, Vcam1 may play an important role in dysregulation of biological functions of EC_ EndMT. Molecular docking results of the quercetin-VCAM1 complex suggest that quercetin may be an effective drug for targeting this protein.
Insights
This study identifies key endothelial cell subtypes and their communication pathways involved in diabetes development. VCAM1, a crucial protein, shows altered expression and may be a therapeutic target for diabetes-related neurodegenerative diseases.
Area of Science:
- Cardiovascular Biology
- Endothelial Cell Biology
- Diabetes Pathophysiology
Background:
- Endothelial cells are critical in diabetes-related neurodegenerative diseases.
- Understanding endothelial cell mechanisms in diabetes is essential for therapeutic development.
Purpose of the Study:
- To investigate the role and mechanisms of endothelial cells in diabetes development.
- To identify specific endothelial cell subtypes and their interactions in cardiovascular tissues during diabetes progression.
Main Methods:
- Single-cell RNA sequencing to identify endothelial cell subtypes.
- Cell-cell communication analysis to map ligand-receptor interactions.
- Differential gene expression analysis to identify diabetes-related genes.
- Cell trajectory inference to track developmental changes.
- Gene Set Enrichment Analysis (GSEA) for functional insights.
- Molecular dynamics simulations (MDSs) for drug target identification.
Main Results:
- Identified seven cell types, including five endothelial cell subtypes (EC_1, EC_2, EC_3, EC_4, EC_EndMT) in mouse heart and aorta.
- Discovered five key ligand-receptor-associated genes (Fn1, Vcam1, Fbn1, Col4a1, Col4a2), with VCAM1 prominently expressed in EC_EndMT.
- Observed cell trajectory shifts towards EC_EndMT and subsequent changes during diabetes progression.
- GSEA indicated that VCAM1 upregulation may inhibit cell growth and energy metabolism.
Conclusions:
- Endothelial cell subtype EC_EndMT plays a complex role in diabetes-related neurodegenerative diseases.
- VCAM1 is implicated in the dysregulation of EC_EndMT biological functions via cell-cell communication.
- Quercetin shows potential as a therapeutic agent targeting VCAM1, as predicted by molecular docking.
Related Concept Videos
Inhibition of Cdk Activity
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...


